1. Home
  2. Labeler Index
  3. Celltrion Usa, Inc.
  4. 72606-051
  5. Product Images: Tocilizumab-anoh

Product Images Tocilizumab-anoh

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Figure 1 - tocilizumab 01
  2. Figure 2 - tocilizumab 02
  3. Figure A - tocilizumab 03
  4. Figure B - tocilizumab 04
  5. Figure C - tocilizumab 05
  6. Figure D - tocilizumab 06
  7. Figure E - tocilizumab 07
  8. Figure F - tocilizumab 08
  9. Figure G - tocilizumab 09
  10. Figure H - tocilizumab 10
  11. Figure I - tocilizumab 11
  12. Figure J - tocilizumab 12
  13. Figure K - tocilizumab 13
  14. Figure L - tocilizumab 14
  15. Figure M - tocilizumab 15
  16. Figure N - tocilizumab 16
  17. Figure A - tocilizumab 17
  18. Figure B - tocilizumab 18
  19. Figure C - tocilizumab 19
  20. Figure D - tocilizumab 20
  21. Figure E - tocilizumab 21
  22. Figure F - tocilizumab 22
  23. Figure G - tocilizumab 23
  24. Figure H - tocilizumab 24
  25. Figure I - tocilizumab 25
  26. Figure J - tocilizumab 26
  27. Figure K - tocilizumab 27
  28. Figure L - tocilizumab 28
  29. Figure M - tocilizumab 29
  30. Figure N - tocilizumab 30
  31. Figure O - tocilizumab 31
  32. Principal Display Panel - 80 mg/4 mL Vial Carton - tocilizumab 32
  33. Principal Display Panel - 200 mg/10 mL Vial Carton - tocilizumab 33
  34. Principal Display Panel - 400 mg/20 mL Vial Carton - tocilizumab 34
  35. Principal Display Panel - 162 mg/0.9 mL Autoinjector Carton - tocilizumab 35

Product Label Images

The following 35 images provide visual information about the product associated with Tocilizumab-anoh NDC 72606-051 by Celltrion Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - tocilizumab 01

Figure 1 - tocilizumab 01

Figure 2 - tocilizumab 02

Figure 2 - tocilizumab 02

Figure A - tocilizumab 03

Figure A - tocilizumab 03

This text appears to be a list of items related to a medical device or tool. It includes terms such as "Plunger", "White", "Finger", "Flange", "Viewing", "Medicine Window", "Needle", "Guard", and "After Use". These items are likely components or features of a product that is used before and after use.*

Figure B - tocilizumab 04

Figure B - tocilizumab 04

A description of the contents of a medical kit which includes a carton with a prefilled syringe, cotton ball or gauze, alcohol swab, adhesive bandage, and a FDA-cleared sharps disposal container.*

Figure C - tocilizumab 05

Figure C - tocilizumab 05

Figure D - tocilizumab 06

Figure D - tocilizumab 06

Figure E - tocilizumab 07

Figure E - tocilizumab 07

Figure F - tocilizumab 08

Figure F - tocilizumab 08

Figure G - tocilizumab 09

Figure G - tocilizumab 09

Figure H - tocilizumab 10

Figure H - tocilizumab 10

Figure I - tocilizumab 11

Figure I - tocilizumab 11

Figure J - tocilizumab 12

Figure J - tocilizumab 12

Figure K - tocilizumab 13

Figure K - tocilizumab 13

Figure L - tocilizumab 14

Figure L - tocilizumab 14

Figure M - tocilizumab 15

Figure M - tocilizumab 15

Figure N - tocilizumab 16

Figure N - tocilizumab 16

Figure A - tocilizumab 17

Figure A - tocilizumab 17

This text provides instructions and details about a medical device before and after use. It includes information about an expiration date, an orange indicator to show that the injection is complete, and a blue needle cover that is locked with the needle inside after use. The text seems to be a label or guide for using the device safely and effectively.*

Figure B - tocilizumab 18

Figure B - tocilizumab 18

This text appears to be a list of the contents of a carton, which include cotton balls, an auto-injector, gauze, alcohol swab, adhesive bandage, and a sharps disposal container. The items mentioned seem to be for medical or health-related purposes.*

Figure C - tocilizumab 19

Figure C - tocilizumab 19

Figure D - tocilizumab 20

Figure D - tocilizumab 20

Figure E - tocilizumab 21

Figure E - tocilizumab 21

Figure F - tocilizumab 22

Figure F - tocilizumab 22

Figure G - tocilizumab 23

Figure G - tocilizumab 23

Figure H - tocilizumab 24

Figure H - tocilizumab 24

Figure I - tocilizumab 25

Figure I - tocilizumab 25

Figure J - tocilizumab 26

Figure J - tocilizumab 26

Figure K - tocilizumab 27

Figure K - tocilizumab 27

Figure L - tocilizumab 28

Figure L - tocilizumab 28

Figure M - tocilizumab 29

Figure M - tocilizumab 29

Figure N - tocilizumab 30

Figure N - tocilizumab 30

Figure O - tocilizumab 31

Figure O - tocilizumab 31

Principal Display Panel - 80 mg/4 mL Vial Carton - tocilizumab 32

Principal Display Panel - 80 mg/4 mL Vial Carton - tocilizumab 32

Principal Display Panel - 200 mg/10 mL Vial Carton - tocilizumab 33

Principal Display Panel - 200 mg/10 mL Vial Carton - tocilizumab 33

Principal Display Panel - 400 mg/20 mL Vial Carton - tocilizumab 34

Principal Display Panel - 400 mg/20 mL Vial Carton - tocilizumab 34

This is a description of Tocilizumab-anoh, an injection with a concentration of 400 mg/20 mL (20 mg/mL), intended for intravenous infusion after dilution. It comes in a single-dose vial which should be refrigerated at 2°C to 8°C (36°F to 46°F) to protect it from light. Each vial contains a solution with various components like tocilzumab-anoh, histidine, methionine, and more. The solution has a pH of 6.0 and does not contain any preservatives. The product is manufactured by CELLTRON, Inc in South Korea and distributed by CELLTRION USA, Inc in the USA. The dosage details are provided in the prescribing information.*

Principal Display Panel - 162 mg/0.9 mL Autoinjector Carton - tocilizumab 35

Principal Display Panel - 162 mg/0.9 mL Autoinjector Carton - tocilizumab 35

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.